Novartis’ Kisqali shows 25% reduction in breast cancer recurrence
HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.
Health
Medical
Contraceptive pills ‘slightly’ increase risk of breast cancer, says study
Progestin-only contraceptive use increases breast cancer risk similarly to combined contraceptive use.